Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes

Scientific Data

Volumn 2, Issue , 2015, Pages

  Wruck, Wasco ^a   Kashofer, Karl ^b   Rehman, Samrina ^c   Daskalaki, Andriani ^d   Berg, Daniela ^e   Gralka, Ewa ^f   Jozefczuk, Justyna ^d   Drews, Katharina ^d   Pandey, Vikash ^d   Regenbrecht, Christian ^g   Wierling, Christoph ^d   Turano, Paola ^f   Korf, Ulrike ^e   Zatloukal, Kurt ^b   Lehrach, Hans ^d   Westerhoff, Hans V ^c,h,i   Adjaye, James ^a,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF FLORENCE   (Italy)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h VU UNIVERSITY AMSTERDAM   (Netherlands)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONUTRIN, HUMAN; APOLIPOPROTEIN C3; LECTIN; MEMBRANE PROTEIN; NCAN PROTEIN, HUMAN; NERVE PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PPP1R3B PROTEIN, HUMAN; PROTEOCHONDROITIN SULFATE; TM6SF2 PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE;

BIOPSY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEIN C-III; BIOPSY; CHONDROITIN SULFATE PROTEOGLYCANS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LECTINS, C-TYPE; LIPASE; LIVER; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN PHOSPHATASE 1;

EID: 84960976467     PISSN: None     EISSN: 20524463     Source Type: Journal    
DOI: 10.1038/sdata.2015.68     Document Type: Article

References (29)

1. Lazo, M. & Clark, J. M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28, 339-350 (2008).
2. Petersen, K. F. et al. Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease. N. Engl. J. Med. 362, 1082-1089 (2010).
3. Speliotes, E. K. et al. Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits. PLoS Genet 7, e1001324 (2011).
4. Samocha-Bonet, D. et al. Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans. PLoS ONE 7, e36320 (2012).
5. Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372-384 (2010).
6. Farese, R. V. Jr., Zechner, R., Newgard, C. B. & Walther, T. C. The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance. Cell Metab. 15, 570-573 (2012).
7. Samuel, V. T. et al. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease. J. Biol. Chem. 279, 32345-32353 (2004).
8. Rajpathak, S. N. et al. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes 61, 2248-2254 (2012).
9. Völzke, H. et al. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur. J. Endocrinol. 161, 705-713 (2009).
10. Aleem, E., Nehrbass, D., Klimek, F., Mayer, D. & Bannasch, P. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis. Toxicol. Pathol. 39, 524-543 (2011).
11. Baffy, G., Brunt, E. M. & Caldwell, S. H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace. J. Hepatol. 56, 1384-1391 (2012).
12. Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. & Tiribelli, C. Molecular basis and mechanisms of progression of nonalcoholic steatohepatitis. Trends Mol. Med. 14, 72-81 (2008).
13. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231 (2002).
14. Jozefczuk, J. et al. A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells. Front. Physiol 3, 339 (2012).
15. Houstis, N., Rosen, E. D. & Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948 (2006).
16. Findeisen, H. M. et al. Glutathione Depletion Prevents Diet-Induced Obesity and Enhances Insulin Sensitivity. Obesity 19, 2429-2432 (2011).
17. Hayes, J. D., Flanagan, J. U. & Jowsey, I. R. Glutathione Transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88 (2005).
18. Moylan, C. A. et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatol. Baltim. Md 59, 471-482 (2014).
19. Kahali, B. et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology 148, 679-684 (2015).
20. Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352-356 (2014).
21. Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187-196 (2015).
22. Feldstein, A. E. et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepatology 50, 1072-1078 (2009).
23. Du Plessis, J. et al. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology 149, 635-648, e14 (2015).
24. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
25. Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321 (2005).
26. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
27. Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
28. Smyth, G. K. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Stat. Appl. Genet. Mol. Biol. 3 doi:10.2202/1544-6115.1027 (2004).
29. Ayonrinde, O. T. et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatol. Baltim. Md 53, 800-809 (2011).